Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1

2005-10-01

Digestive Diseases and Sciences , Volume 50 - Issue 10 p. 1804- 1806

Additional Metadata
Keywords	End-stage renal failure, Hepatitis C, Membranoproliferative glomerulonephritis, Nephrotic syndrome, Peginterferon, Ribavirin
Persistent URL	doi.org/10.1007/s10620-005-2941-x, hdl.handle.net/1765/57583
Journal	Digestive Diseases and Sciences
Organisation	Department of Pharmacy
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Orlent, H., Mathot, R., van Bommel, E., Vulto, A., Schalm, S., & Brouwer, J. (2005). Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1. Digestive Diseases and Sciences, 50(10), 1804–1806. doi:10.1007/s10620-005-2941-x

Publication